Health Care: Drugs

Anacor Pharmaceuticals Inc (ANAC: NASDAQ)

$134.66 n/a | n/a%
09/02/15 - 03:59 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 20.69M 17.23M 10.74M 20.31M
Cost of Sales 797.00K 0.00 0.00 0.00
Gross Operating Profit 19.89M 17.23M 10.74M 20.31M
Selling, General, and Administrative Expenses 31.39M 20.65M 11.61M 10.55M
Research & Development 72.49M 46.56M 52.32M 56.10M
Operating Income before D & A (EBITDA) -84.00M -49.98M -53.19M -46.34M
Depreciation & Amortization 3.27M 1.65M 1.70M 2.36M
Interest Income 320.00K 55.00K 72.00K 148.00K
Other Income - Net -2.41M -2.05M -53.00K -353.00K
Special Income / Charges -6.80M 142.50M 0.00 0.00
Total Income Before Interest Expenses (EBIT) -96.16M 88.87M -54.87M -48.91M
Interest Expense 4.52M 4.05M 2.91M 1.40M
Pre-Tax Income -100.68M 84.82M -57.78M -50.31M
Income Taxes -10.26M 1.71M 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -87.15M 84.76M -56.09M -47.94M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -87.15M 84.76M -56.09M -47.94M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -87.15M 84.76M -56.09M -47.94M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-80.35M -57.74M -56.09M -47.94M
Preferred Dividends
Net Income Available To Common -87.15M 84.76M -56.09M -47.94M
Basic EPS from Continuing Ops. -2.06 2.16 -1.76 -1.71
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.06 2.16 -1.76 -1.71
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.06 2.16 -1.76 -1.71
Basic Normalized Net Income/Share -1.90 -1.47 -1.76 -1.71
EPS fr Continuing Ops. -2.06 2.10 -1.76 -1.71
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.06 2.10 -1.76 -1.71
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.06 2.10 -1.76 -1.71
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.90 -1.43 -1.76 -1.71
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ANAC

Latest ANAC Headlines from TheStreet

More Financial News for ANAC

Press Releases for ANAC

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter